This inventor holds 8 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Wave Life Sciences Ltd.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Nenad Svrzikapa in Oligonucleotide Design
Introduction
Nenad Svrzikapa, an accomplished inventor based in Cambridge, MA, has made significant strides in the realm of oligonucleotide technology. With a total of eight patents to his name, his work primarily focuses on chirally controlled oligonucleotides, which hold promising applications in various fields, including biotechnology and pharmaceuticals.
Latest Patents
Among his latest innovations, Svrzikapa has developed patents related to chirally controlled oligonucleotides. One notable patent discusses “Chiral Design,” which explores chirally controlled oligonucleotide compositions and the methods associated with their production and application. This invention reveals that certain chirally controlled oligonucleotide compositions can produce different cleavage patterns of nucleic acid polymers compared to reference compositions, emphasizing its potential efficacy in genetic research and therapeutic applications.
Another of his key patents is titled “Chiral Control.” This invention identifies issues in prior methodologies for creating chiral oligonucleotides, addressing difficulties that hinder the preparation of fully chirally controlled compositions. Svrzikapa provides innovative methods for making these chirally controlled oligonucleotides and their compositions, paving the way for advancements in oligonucleotide applications.
Career Highlights
Currently, Svrzikapa is associated with Wave Life Sciences Ltd., where he continues to push the boundaries of scientific discovery in the field of molecular medicine. His career reflects a commitment to innovation and the practical application of his research findings.
Collaborations
He is known for his collaborative efforts with prominent scientists, including Meena and Gregory Lawrence Verdine. These partnerships highlight a shared dedication to advancing the understanding and utility of oligonucleotide technologies, fostering an environment where innovative ideas thrive.
Conclusion
Nenad Svrzikapa’s contributions to the field of oligonucleotide research through his patents and collaborations mark him as a notable figure in innovation. As his work continues to develop, it holds great potential for transformative impacts in scientific and medical arenas, reaffirming the importance of inventors in shaping future technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
